Table 1.
Efficacy attribute | Ranking | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
Reduces disease activity overall | Alemtuzumab | Cladribine tablets | Ocrelizumab | Natalizumab | Fingolimod |
DMD disease-modifying drug
Efficacy attribute | Ranking | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
Reduces disease activity overall | Alemtuzumab | Cladribine tablets | Ocrelizumab | Natalizumab | Fingolimod |
DMD disease-modifying drug